actinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine

C57H48AcN23- — CID 161492018

IUPACactinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine
SMILESCc1cc(Nc2ncnc3ccccc23)n[nH]1.[Ac].[NH-]c1ccc(Nc2nc(Nc3ccn[nH]3)c3ccccc3n2)cc1.c1ccc(Nc2nc(Nc3ccn[nH]3)c3ccccc3n2)cc1.c1ccc2c(Nc3ccn[nH]3)ncnc2c1
InChIInChI=1S/C17H14N7.C17H14N6.C12H11N5.C11H9N5.Ac/c18-11-5-7-12(8-6-11)20-17-21-14-4-2-1-3-13(14)16(23-17)22-15-9-10-19-24-15;1-2-6-12(7-3-1)19-17-20-14-9-5-4-8-13(14)16(22-17)21-15-10-11-18-23-15;1-8-6-11(17-16-8)15-12-9-4-2-3-5-10(9)13-7-14-12;1-2-4-9-8(3-1)11(13-7-12-9)15-10-5-6-14-16-10;/h1-10,18H,(H3,19,20,21,22,23,24);1-11H,(H3,18,19,20,21,22,23);2-7H,1H3,(H2,13,14,15,16,17);1-7H,(H2,12,13,14,15,16);/q-1;;;;
InChIKeyALIOUDOJOYMFAC-UHFFFAOYSA-N
MW1282.17 g/mol
LogP12.87
Rot. Bonds12

About actinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine

actinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine (PubChem CID 161492018) has the molecular formula C57H48AcN23- and a molecular weight of 1282.17 g/mol. Its IUPAC name is actinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine.

Molecular Properties

Compound Nameactinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine
PubChem CID161492018
Molecular FormulaC57H48AcN23-
Molecular Weight1282.17 g/mol
Exact Mass1281.47
IUPAC Nameactinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine
SMILESCc1cc(Nc2ncnc3ccccc23)n[nH]1.[Ac].[NH-]c1ccc(Nc2nc(Nc3ccn[nH]3)c3ccccc3n2)cc1.c1ccc(Nc2nc(Nc3ccn[nH]3)c3ccccc3n2)cc1.c1ccc2c(Nc3ccn[nH]3)ncnc2c1
InChIInChI=1S/C17H14N7.C17H14N6.C12H11N5.C11H9N5.Ac/c18-11-5-7-12(8-6-11)20-17-21-14-4-2-1-3-13(14)16(23-17)22-15-9-10-19-24-15;1-2-6-12(7-3-1)19-17-20-14-9-5-4-8-13(14)16(22-17)21-15-10-11-18-23-15;1-8-6-11(17-16-8)15-12-9-4-2-3-5-10(9)13-7-14-12;1-2-4-9-8(3-1)11(13-7-12-9)15-10-5-6-14-16-10;/h1-10,18H,(H3,19,20,21,22,23,24);1-11H,(H3,18,19,20,21,22,23);2-7H,1H3,(H2,13,14,15,16,17);1-7H,(H2,12,13,14,15,16);/q-1;;;;
InChIKeyALIOUDOJOYMFAC-UHFFFAOYSA-N
XLogP12.87
TPSA313.82 Ų
H-Bond Donors10
H-Bond Acceptors18
Rotatable Bonds12
Heavy Atoms81
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001282.17
LogP ≤ 512.87
H-Bond Donors ≤ 510
H-Bond Acceptors ≤ 1018

Analyze actinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-N-(5-methyl-1H-pyrazol-3-yl)-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine
CID 20604329
4-N-(5-methyl-1H-pyrazol-3-yl)-2-N-(3-phenylphenyl)quinazoline-2,4-diamine
CID 10178621
2-N-(2-fluorophenyl)-4-N-(5-methyl-1H-pyrazol-3-yl)quinazoline-2,4-diamine
CID 170946131
N-[2-methyl-4-[[4-[(5-methyl-1H-pyrazol-3-yl)amino]quinazolin-2-yl]amino]phenyl]acetamide
CID 10110761
2-N-[(3-fluorophenyl)methyl]-4-N-(5-methyl-1H-pyrazol-3-yl)quinazoline-2,4-diamine
CID 170000713
2-N-(4-fluorophenyl)-4-N-phenylquinazoline-2,4-diamine;hydrochloride
CID 67720007
2-N-(3-methylphenyl)-4-N-phenylquinazoline-2,4-diamine
CID 71690518
2-(2-chlorophenyl)sulfanyl-N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine
CID 10270356
2-N-(4-chlorophenyl)-4-N-phenylquinazoline-2,4-diamine;hydrochloride
CID 67720832
4-N-(5-cyclopropyl-1H-pyrazol-3-yl)-2-N-[4-(methylsulfonylmethyl)phenyl]quinazoline-2,4-diamine
CID 177020193
4-N-(5-methyl-1H-pyrazol-3-yl)-2-N-phenylpyrrolo[2,1-f][1,2,4]triazine-2,4-diamine
CID 91431192
2-N-(3,5-dichlorophenyl)-4-N-phenylquinazoline-2,4-diamine
CID 71690550

Frequently Asked Questions

What is the IUPAC name of actinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine?
The IUPAC name of actinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine (CID 161492018) is actinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine.
What is the SMILES notation for actinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine?
The canonical SMILES for actinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine is Cc1cc(Nc2ncnc3ccccc23)n[nH]1.[Ac].[NH-]c1ccc(Nc2nc(Nc3ccn[nH]3)c3ccccc3n2)cc1.c1ccc(Nc2nc(Nc3ccn[nH]3)c3ccccc3n2)cc1.c1ccc2c(Nc3ccn[nH]3)ncnc2c1.
What is the InChIKey of actinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine?
The InChIKey is ALIOUDOJOYMFAC-UHFFFAOYSA-N. The full InChI is InChI=1S/C17H14N7.C17H14N6.C12H11N5.C11H9N5.Ac/c18-11-5-7-12(8-6-11)20-17-21-14-4-2-1-3-13(14)16(23-17)22-15-9-10-19-24-15;1-2-6-12(7-3-1)19-17-20-14-9-5-4-8-13(14)16(22-17)21-15-10-11-18-23-15;1-8-6-11(17-16-8)15-12-9-4-2-3-5-10(9)13-7-14-12;1-2-4-9-8(3-1)11(13-7-12-9)15-10-5-6-14-16-10;/h1-10,18H,(H3,19,20,21,22,23,24);1-11H,(H3,18,19,20,21,22,23);2-7H,1H3,(H2,13,14,15,16,17);1-7H,(H2,12,13,14,15,16);/q-1;;;;.
What are the key properties of actinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine?
actinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine has a molecular weight of 1282.17 g/mol, XLogP of 12.87, 12 rotatable bonds, 10 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for actinium;N-(5-methyl-1H-pyrazol-3-yl)quinazolin-4-amine;2-N-phenyl-4-N-(1H-pyrazol-5-yl)quinazoline-2,4-diamine;[4-[[4-(1H-pyrazol-5-ylamino)quinazolin-2-yl]amino]phenyl]azanide;N-(1H-pyrazol-5-yl)quinazolin-4-amine is sourced from PubChem (CID 161492018), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).